NasdaqGS - Delayed Quote USD
Revolution Medicines, Inc. (RVMD)
At close: 4:00 PM EDT
After hours: 4:20 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Operating Cash Flow
-509,787.00
-350,572.00
-224,401.00
-147,180.00
-100,064.00
--
Investing Cash Flow
-443,072.00
-342,598.00
-24,116.00
-142,117.00
-234,233.00
--
Financing Cash Flow
848,679.00
1,229,200.00
301,432.00
294,179.00
422,776.00
--
End Cash Position
278,744.00
699,179.00
163,149.00
110,234.00
105,352.00
--
Capital Expenditure
-10,418.00
-7,729.00
-10,816.00
-6,528.00
-2,933.00
--
Issuance of Capital Stock
--
385,759.00
298,045.00
291,241.00
420,067.00
--
Free Cash Flow
-520,205.00
-358,301.00
-235,217.00
-153,708.00
-102,997.00
--
12/31/2019 - 2/13/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
KYMR Kymera Therapeutics, Inc.
48.37
+3.89%
PTGX Protagonist Therapeutics, Inc.
46.44
+1.04%
PCVX Vaxcyte, Inc.
112.66
-2.42%
CYTK Cytokinetics, Incorporated
54.94
+2.10%
ACLX Arcellx, Inc.
90.46
+0.20%
NUVL Nuvalent, Inc.
102.51
+1.33%
ASND Ascendis Pharma A/S
129.07
+0.32%
RLAY Relay Therapeutics, Inc.
6.66
+3.58%
LEGN Legend Biotech Corporation
45.04
+3.65%
EWTX Edgewise Therapeutics, Inc.
34.42
-1.23%